Research Studies
Study Title
Cytokinetics VITALITY Trial (Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year)
Enrollment Status
Completed
Principal Investigators
Site-PI: Michael Benatar, MD, PhD
Study Type
Drug Trial
Goals
- To assess the effect of tirasemtiv versus placebo on respiratory function in patients with ALS.
Enrolling
ALS patients
Eligibility
Click to Expand
Study Involvement
Click to Expand
Contact
Links
Primary Funding Source
Cytokinetics
Related Publications
Click to Expand
Shefner JM, Cudkowicz ME, Hardiman O, Cockcroft BM, Lee JH, Malik FI, Meng L, Rudnicki SA, Wolff AA, Andrews JA; VITALITY-ALS Study Group. A phase III trial of tirasemtiv as a potential treatment for amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2019;0(0):1-11.
Related Presentations & Lectures
Click to Expand
No items found